Financhill
Back

Atkinsrealis Group Vs. Kymera Therapeutics Industry Stock Comparison

Buy
84

ATRL.TO
Atkinsrealis Group

Last Price:
65.70
Seasonality Move:
9.6%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.30
Seasonality Move:
65.72%
Buy
84
Atkinsrealis Group (ATRL.TO) is a Buy

Is Atkinsrealis Group a Buy, Sell or Hold?

  • The current Atkinsrealis Group [ATRL.TO] share price is $63.63. The Score for ATRL.TO is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • ATRL.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ATRL.TO Stock Price Chart

What is Atkinsrealis Group's stock price today?

  • The Atkinsrealis Group share price today is $63.63
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRL.TO is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATRL.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.45 Buy
Relative Strength Index (14 RSI): 82.65 Buy
Chaikin Money Flow: 176264 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.38 - 59.52) Buy
Bollinger Bands (100): (52.45 - 58.63) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

ATRL.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.51 Buy
20-day SMA: 56.74 Buy
50-day SMA: 54.31 Buy
200-day SMA: 52.81 Buy
8-day EMA: 60.57 Buy
20-day EMA: 57.7 Buy
50-day EMA: 55.72 Buy
200-day EMA: 52.17 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Atkinsrealis Group Earnings Growth & ATRL.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.83 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Atkinsrealis Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):